SA analyst downgrades: AAPL, SMCI, MRNA, TRIP, IIPR, STLA, TWST - MSN
Yesterday • Google News
Twist Bioscience Corp (TWST)
US$ 39.244.06%
Price Chart
Key Statistics
Market Cap
$ 1.82B
P/E Ratio
0.00
Revenue (TTM)
$ 347.68M
Volume
1.46M
52W High
$ 60.90
52W Low
$ 28.46
Dividend Yield
0.00%
Beta
2.54
Technicals
50-Day MA
37.6942
200-Day MA
43.4249
52 Week High
60.9
52 Week Low
28.46
About TWST
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemi.
Employees
923
Headquarters
South San Francisco, CA
CEO
Dr. Emily Marine Leproust Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg